Describing the development of molecular research in the context of nervous system diseases using year-based h- cores

Abstract

This article introduces year-based h-indices as a tool to produce easy-to-use research overviews. Based on PubMed data, a general framework is constructed to study the development of molecular research in the context of nervous system diseases. It is shown which molecular substances are the centre of attention and which have passed their peak. Year-based h-indices have the following interesting features for representing changes in a field or discipline: flexibility, sensitivity to dynamic changes, fluctuation detection and trend detection.

Keywords

dynamic overview molecular substances nervous system diseases

Get full access to this article

View all access options for this article.

References

Leydesdorff

. The delineation of nanoscience and nanotechnology in terms of journals and patents: A most recent update. Scientometrics 2008; 76(1): 159–167.

Samoylenko

Chao

Liu

. Visualizing the scientific world and its evolution. Journal of the American Society for Information Science and Technology 2006; 57(11):1461–1469.

Skupin

Biberstine

Börner

. Visualizing the topical structure of the medical sciences: A self-organizing map approach. PLoS ONE 2013; 8(3): e58779.

van Eck

Waltman

. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 2010; 84(2): 523–538.

Hirsch

. An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences of the USA 2005; 102(46): 16569–16572.

Liang

Rousseau

. A general approach to citation analysis and an h-index based on the standard impact factor framework. In: Larsen

Leta

(eds) ISSI 2009; 12th International Conference on Scientometrics and Informetrics, Rio de Janeiro, Brazil, 2009, pp. 143–153. Rio de Janeiro: BIREME & Federal University of Rio de Janeiro.

Braun

Glänzel

Schubert

. A Hirsch-type index for journals. Scientometrics 2006; 69 (1): 169–173.

Banks

. An extension of the Hirsch index: Indexing scientific topics and compounds. Scientometrics 2006; 69(1): 161–168.

Liu

Rousseau

. Properties of Hirsch-type indices: The case of library classification categories. Scientometrics 2009; 79(2): 235–248.

10.

Egghe

. The Hirsch index and related impact measures. Annual Review of Information Science and Technology 2010; 44(1): 65–114.

11.

Alonso

Cabrerizo

Herrera-Viedma

. H-Index: A review focused in its variants, computation and standardization for different scientiﬁc ﬁelds. Journal of Informetrics 2009; 3(4): 273–289.

12.

Jin

Liang

Rousseau

. The R- and AR-indices: Complementing the h-index. Chinese Science Bulletin 2007; 52(6): 855–863.

13.

Mahbuba

Rousseau

. Year-based h-type indicators. Scientometrics, 2013,; 96(3), 785–797.

14.

Cesca

Baldelli

Valtorta

. The synapsins: Key actors of synapse function and plasticity. Progress in Neurobiology 2010; 91(4): 313–348.

15.

Crews

Masliah

. Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Human Molecular Genetics 2010; 19 (R1): R12–20.

16.

Zhao

Kier

Buck

. Systems biology: Molecular networks and disease. Chemistry & Biodiversity 2012; 9(5): 841–847.

17.

Zhao

Strotmann

. Mapping molecular association networks of nervous system diseases via large-scale analysis of published research. PLoS One 2013, 8(6): e67121; doi:10.1371/journal.pone.0067121

18.

Baranzini

. Revealing the genetic basis of multiple sclerosis: Are we there yet? Current Opinion in Genetics and Development 2011; 21(3): 317–324.

19.

NCBI.MeSH:HLA-DQ Antigens 1989. Available at: http://www.ncbi.nlm.nih.gov/mesh/?term=HLA-DQ+Antigens (accessed 28 April 2013).

20.

Lin

Hungs

Mignot

. Narcolepsy and the HLA region. Journal of Neuroimmunology 2001; 117(1–2): 9–20.

21.

Finkel

. Read-through strategies for suppression of nonsense mutations in Duchenne/Becker muscular dystrophy: Aminoglycosides and ataluren (PTC124). Journal of Child Neurology 2010; 25(9): 1158–1164.

22.

Grandy

. Biomarkers and gene mutations as aids for detecting AD early. Journal of American Academy of Physician Assistants 2011; 24(6): 56–57.

23.

Leandro

Saraste

Leandro

. The G46S-hPAH mutant protein: A model to study the rescue of aggregation-prone PKU mutations by chaperones. Molecular Genetics and Metabolism 2011; 104(suppl.): S40–S44.

24.

Scriver

. The PAH gene, phenylketonuria, and a paradigm shift. Human Mutation 2007; 28(9): 831–845.

25.

Chiocca

. Gene therapy: A primer for neurosurgeons. Neurosurgery 2003; 53(2): 364–373.

26.

Gitler

Bevis

Shorter

. The Parkinson’s disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proceedings of the National Academy of Sciences of the USA 2008; 105(1): 145–150.

27.

Larner

Doran

. Genotype–phenotype relationships of presenilin-1 mutations in Alzheimer’s disease: An update. Journal of Alzheimer’s Disease 2009; 17(2): 259–265.

28.

Wolk

Dickerson

. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease. Proceedings of the National Academy of Sciences of the USA 2010; 107(22): 10256–10261.

29.

Olanow

McNaught

. Parkinson’s disease, proteins, and prions: Milestones. Movement Disorder 2011; 26(6): 1056–1071.

30.

Yates

. Neurodegenerative disease: Neurodegenerative networking. Nature Reviews Neuroscience 2012; 13(2): 288–289.

31.

NCBI. MeSH: HLA-DQ alpha-chains, 2012. Available at: http://www.ncbi.nlm.nih.gov/mesh/68059848 (accessed 28 April 2013).

32.

NCBI. MeSH: HLA-DQ beta-chains, 2012. Available at: http://www.ncbi.nlm.nih.gov/mesh/68059866 (accessed 28 April 2013).

33.

Megiorni

Pizzuti

. HLA-DQA1 and HLA-DQB1 in celiac disease predisposition: Practical implications of the HLA molecular typing. Journal of Biomedical Science 2012; 19(1): 88–97.